51 /100
HIGH RISK
Score updated Jul 14, 2026

BDPT — BioAdaptives, Inc. Dilution Risk Tracker

Track BDPT dilution risk with DilutionWatch's stock tracker. DilutionScore™ measures dilution risk across 5 factors — lower scores indicate higher risk of share dilution.

⚠️ Not financial advice. Do your own research before making any investment decisions.

🔔 Track BDPT — Get alerts when the score changes →

As of July 14, 2026, BioAdaptives, Inc. (BDPT) has a DilutionWatch DilutionScore of 51/100, rated HIGH dilution risk. BioAdaptives, Inc. has a market capitalization of $108.1K, 12.01M shares outstanding. Key dilution vectors include 200.0K outstanding warrants, approximately 11 months of cash runway.

Source: DilutionWatch (dilutionwatch.com) — data updated daily from SEC EDGAR filings. Not financial advice.

📊 Score Breakdown

📋 Offering Ability
52
💰 Cash Runway
65
📊 Float Risk
22
⚠️ Warrant Exposure
15
🔄Convertible Debt

🌦️ Dilution Forecast

⛈️
Warning
High probability of dilution event
53%
🔄 Reverse Split 65%
• 50-day avg $0.01 below $1 exchange minimum
• 11 months cash with weak price
🔁 Convertible Conversion 60%
• Major convertible overhang: 236% potential dilution
• Convertible risk score very high (85/100)
💰 Capital Raise 15%
• Under 12 months cash (11mo)
🔔 Track BDPT — Get forecast alerts →

💹 Market Data

Market Cap$108.1K
Shares Outstanding12.01M
FloatN/A
Cash$215.2K
DebtN/A
Short InterestN/A

🏛 Institutional Holdings

Institutional data not yet available.

📉 Short Interest

Short Interest51.8K
Days to Cover1.0
% of FloatN/A
FINRA data as of Jun 30, 2026

📁 Recent SEC Activity

xbrl XBRL WARRANT Jul 07, 2026
xbrl XBRL CONVERTIBLE Mar 31, 2026
Full SEC filing analysis available with free account

📰 Recent News

No recent news

📋 What This Means for BDPT Shareholders

BioAdaptives, Inc. (BDPT) has a DilutionScore of 51/100, placing it in the High dilution risk tier. This score reflects at least one active dilution mechanism — a shelf registration, ATM program, outstanding warrants, or limited cash runway — that could materially increase the share count over the next 12–18 months. Score as of July 14, 2026, updated from SEC EDGAR data.

DilutionWatch tracks 200,000 outstanding warrants for BDPT. Warrants become dilutive when exercised — converting to common shares at the strike price. Warrants near or in-the-money deserve particular attention since exercise can add materially to the outstanding share count within a short window. Cash runway is a key watch item: BDPT has approximately 11 months of runway at current burn rate. Companies with less than 18 months of runway are statistically more likely to file new shelf registrations or ATM programs within the next two quarters. DilutionWatch monitors SEC 10-Q filings to update this estimate each quarter.

DilutionWatch tracks over 25 SEC filing types for BDPT in real-time, scanning EDGAR every 60 seconds. The DilutionWatch screener shows real-time score changes for BDPT alongside comparable high-risk stocks. Not financial advice — this analysis is for informational purposes only.

Warrants Explained →
Track BDPT Dilution Risk in Real-Time
Get instant alerts when SEC filings impact dilution risk. Free tier available.
Start Tracking BDPT — Free
Real-time SEC alerts DilutionScore™ tracking No credit card required

🔗 Related Stocks — HIGH Risk

Other HIGH dilution risk stocks tracked by DilutionWatch with similar profiles:

Browse all 7,800+ tracked stocks →

📖 Dilution Education
→ Complete Dilution Guide for Retail Investors → Anti-Dilution Provisions Explained → Stock Dilution Red Flags to Watch → Understanding Shelf Registrations
🔬 More Research for BDPT
📊 BDPT FDA Catalyst Timeline & Biotech Grade — BiotechSigns 📡 BDPT Signal Convergence & Dark Pool Activity — StonkWhisper

Part of the Guerilla Finance research network. Cross-reference multiple data sources for better due diligence.